PHILIP STITZER: Open Payments
NPI 1881693323 · MOBERLY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,540 in 91 payments from 22 companies in 2025. Trend: 2023 $1,787 · 2024 $1,974 · 2025 $1,540
Food & beverage: $1,540
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $289 |
| ABBVIE INC. | 16 | $249 |
| Novo Nordisk Inc | 20 | $217 |
| Amgen Inc. | 13 | $197 |
| Lilly USA, LLC | 5 | $102 |
| Viatris Specialty LLC | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| PFIZER INC. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Verona Pharma, Inc. | 2 | $37 |
Products named: AIRSUPRA, OTEZLA, UBRELVY, Wegovy, BREZTRI, VRAYLAR, YUPELRI, Ozempic.
Industry payments across MO — which companies pay providers there.
